KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $6.0 billion.

  • Bristol Myers Squibb's Free Cash Flow rose 1374.6% to $6.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 billion, marking a year-over-year increase of 1086.0%. This contributed to the annual value of $13.9 billion for FY2024, which is 1020.47% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Free Cash Flow stood at $6.0 billion for Q3 2025, which was up 1374.6% from $3.6 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Free Cash Flow ranged from a high of $6.0 billion in Q3 2025 and a low of $1.6 billion during Q2 2023
  • Over the past 5 years, Bristol Myers Squibb's median Free Cash Flow value was $3.6 billion (recorded in 2025), while the average stood at $3.4 billion.
  • Within the past 5 years, the most significant YoY rise in Bristol Myers Squibb's Free Cash Flow was 13632.92% (2021), while the steepest drop was 3466.3% (2021).
  • Bristol Myers Squibb's Free Cash Flow (Quarter) stood at $3.7 billion in 2021, then fell by 20.79% to $3.0 billion in 2022, then surged by 32.5% to $3.9 billion in 2023, then rose by 3.54% to $4.1 billion in 2024, then surged by 47.53% to $6.0 billion in 2025.
  • Its Free Cash Flow was $6.0 billion in Q3 2025, compared to $3.6 billion in Q2 2025 and $1.7 billion in Q1 2025.